New ALS Drug Targets Cell Mutation, May Slow Progression: Study

New ALS Drug Targets Cell Mutation, May Slow Progression: Study The small study suggests that the drug, tofersen, might even be able to slow muscle degeneration and reverse ALS symptoms by targeting a specific mutation — SOD1 mRNA — which affects 2% of people with ALS. Plus: HIV drugs, a Nipah virus vaccine, hydroxychloroquine, and more. https://kffhealthnews.org/morning-breakout/new-als-drug-targets-cell-mutation-may-slow-progression-study/